Expression of thymidylate synthase is correlated with proliferative activity in non-small cell lung cancer (NSCLC)

被引:53
|
作者
Nakagawa, T
Otake, Y
Yanagihara, K
Miyahara, R
Ishikawa, S
Fukushima, M
Wada, H
Tanaka, F
机构
[1] Kyoto Univ, Fac Med, Dept Thorac Surg, Sakyo Ku, Kyoto 6068507, Japan
[2] Taiho Pharmaceut Co Ltd, Inst Appl Oncol, Hanno, Saitam 3578527, Japan
关键词
thymidylate synthase; non-small cell lung cancer; cell proliferation;
D O I
10.1016/j.lungcan.2003.09.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Many experimental studies have revealed that enhanced thymidylate synthase (TS) expression is significantly correlated with higher proliferative activity of tumor cells, which may account for a poor prognosis of high-TS patients. However, only a few clinical studies have focused on the correlation between TS status and cell proliferation. Therefore, we assessed the correlation between TS expression and proliferative index (PI) as a marker of cell proliferation or p53 status in a total of 109 patients with completely resected pathologic stage I, non-small cell lung cancer (NSCLC). PI was defined as the percentage of tumor cells with positive staining against proliferative cell nuclear antigen (PCNA). The mean PIs of TS-high and TS-low tumors were 48.2% and 34.4% respectively, showing a significantly higher proliferative activity of TS-high tumor (P = 0.020); when stratified according to histological type, the difference was significant in adenocarcinoma (P = 0.038), but not in squamous cell carcinoma. There was no significant correlation between TS expression and p53 status. In conclusion, tumor cells with higher TS expression have higher proliferative activity in NSCLC, especially in adenocarcinoma. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:145 / 149
页数:5
相关论文
共 50 条
  • [21] Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS)
    Vassiliki Kotoula
    Dimitrios Krikelis
    Vasilios Karavasilis
    Triantafillia Koletsa
    Anastasia G Eleftheraki
    Despina Televantou
    Christos Christodoulou
    Stefanos Dimoudis
    Ippokratis Korantzis
    Dimitrios Pectasides
    Konstantinos N Syrigos
    Paris A Kosmidis
    George Fountzilas
    BMC Cancer, 12
  • [22] Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS)
    Kotoula, Vassiliki
    Krikelis, Dimitrios
    Karavasilis, Vasilios
    Koletsa, Triantafillia
    Eleftheraki, Anastasia G.
    Televantou, Despina
    Christodoulou, Christos
    Dimoudis, Stefanos
    Korantzis, Ippokratis
    Pectasides, Dimitrios
    Syrigos, Konstantinos N.
    Kosmidis, Paris A.
    Fountzilas, George
    BMC CANCER, 2012, 12
  • [23] DOWNREGULATION OF THYMIDYLATE SYNTHASE WITH ARSENIC TRIOXIDE IN NON-SMALL CELL LUNG CANCER: IN VITRO AND IN VIVO
    Lam, Sze Kwan
    Li, Yuan Yuan
    Zheng, Chun Yan
    Ho, James Chung Man
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1033 - S1033
  • [24] Pemetrexed for Previously Treated Patients with Non-Small Cell Lung Cancer and Differences in Efficacy according to Thymidylate Synthase Expression
    Igawa, Satoshi
    Ryuge, Shinichiro
    Wada, Mayuko
    Otani, Sakiko
    Maki, Sachiyo
    Takakura, Akira
    Katono, Ken
    Sasaki, Jiichiro
    Sato, Yuichi
    Masuda, Noriyuki
    CHEMOTHERAPY, 2012, 58 (04) : 313 - 320
  • [25] INFLUENCE OF EVEROLIMUS AND PEMETREXED ON THYMIDYLATE SYNTHASE EXPRESSION AS WELL AS ON PROLIFERATION AND SURVIVAL OF NON-SMALL CELL LUNG CANCER CELLS
    Markova, B.
    Haehnel, P. S.
    Herbertz, S.
    Schuler, M.
    Breitenbuecher, F.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S56 - S57
  • [26] The pemetrexed-containing treatments in the non-small cell lung cancer, is -/low thymidylate synthase expression better than +/high thymidylate synthase expression: a meta-analysis
    Lei Wang
    Rui Wang
    Yunjian Pan
    Yihua Sun
    Jie Zhang
    Haiquan Chen
    BMC Cancer, 14
  • [27] Epigenetic regulation of prostacyclin synthase (PTGIS) in non-small cell lung cancer (NSCLC)
    Cathcart, M. C.
    Al-Sarraf, N.
    Boyle, E.
    Pidgeon, G. P.
    O'Byrne, K. J.
    Gray, S. G.
    LUNG CANCER, 2009, 63 : S2 - S2
  • [28] Association of thymidylate synthase (TS) expression with response to S-1 plus carboplatin (CBDCA) in non-small cell lung cancer (NSCLC) patients (pts)
    Takeda, M.
    Okamoto, I.
    Fukuoka, A.
    Nakagawa, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] THYMIDYLATE SYNTHASE (TS) MRNA AND PROTEIN EXPRESSION IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH PEMETREXED-BASED THERAPY.
    Monica, Valentina
    Novello, Silvia
    Milella, Michele
    Vavala', Tiziana
    Vari, Sabrina
    Lo Iacono, Marco
    Busso, Simone
    Fora, Gianluca
    Papotti, Mauro
    Scagliotti, Giorgio V.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1085 - S1085
  • [30] β-catenin in non-small cell lung cancer (NSCLC)
    Swinson, DEB
    Lolljee, J
    Edwards, JG
    Jones, JL
    Cox, G
    Richardson, D
    O'Byrne, KJ
    BRITISH JOURNAL OF CANCER, 2002, 86 : S59 - S60